Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Huawei Says It Will Support AI Drug Development Without Developing Drugs

AI summary

Huawei Pharmaceutical Group president Fan Jie said the company will not develop drugs or drug pipelines, according to IT之家. Huawei plans to provide pharmaceutical companies, research institutions and AI drug developers with computing, storage, networking, toolchains and data-governance capabilities. Fan also said some partner projects have begun deploying hundred-GPU computing clusters for training, deploying and optimizing drug-development models.

In-depth insight

The statement clarifies Huawei’s role in AI drug development as an infrastructure and ecosystem provider rather than a drug developer, while the reported cluster deployments show that partner projects have begun using this model.

华为制药军团总裁樊杰明确“华为不做药”,希望成为 AI 制药产业技术底座 - IT之家

首页

IT圈

最会买

设置

  • 日夜间 随系统 浅色 深色
  • 主题色 黑色

#Huawei#Huawei Pharmaceutical Group#DeepWise#StoneWise#MoleculeMind#Shanghai Institute of Materia Medica#Changping Laboratory

Original · 3 min readRead the original
Group chat

No comments yet. Start the conversation.